🇺🇸 FDA
Patent

US 12409205

Nanomolecules for the treatment of inflammatory bowel diseases

granted A61KA61K38/00A61K38/08

Quick answer

US patent 12409205 (Nanomolecules for the treatment of inflammatory bowel diseases) held by Northwestern University expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K47/542